Trastuzumab emtansine is an antibody-drug conjugate (ADC) designed for HER2-positive cancers, delivering the cytotoxic agent DM1 directly to tumor cells. It is widely used in preclinical research, including in vitro cytotoxicity assays and in vivo xenograft models, to study targeted therapy mechanisms and efficacy in advanced breast cancer and other HER2-driven malignancies.
Concentration:
20.5 mg/mL
Purity:
98.00% (May vary between batches)
CAS Number:
[1018448-65-1]
Target:
EGFR,Antibody-Drug Conjugates (ADCs)
* VAT and and shipping costs not included. Errors and price changes excepted